241 related articles for article (PubMed ID: 26138646)
21. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
[TBL] [Abstract][Full Text] [Related]
22. Risk of Rare Cancers Among Solid Organ Transplant Recipients.
D'Arcy ME; Castenson D; Lynch CF; Kahn AR; Morton LM; Shiels MS; Pfeiffer RM; Engels EA
J Natl Cancer Inst; 2021 Feb; 113(2):199-207. PubMed ID: 32462187
[TBL] [Abstract][Full Text] [Related]
23. rs34567942 a Novel Susceptibility Single Nucleotide Polymorphism for Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients.
Kuzmanov A; Qi W; Stenz N; Bochud PY; Kutalik Z; Wojtowicz A; Hofbauer G
Acta Derm Venereol; 2019 Dec; 99(13):1303-1304. PubMed ID: 31573663
[No Abstract] [Full Text] [Related]
24. Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.
Endrizzi B; Ahmed RL; Ray T; Dudek A; Lee P
Dermatol Surg; 2013 Apr; 39(4):634-45. PubMed ID: 23379978
[TBL] [Abstract][Full Text] [Related]
25. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
Krynitz B; Edgren G; Lindelöf B; Baecklund E; Brattström C; Wilczek H; Smedby KE
Int J Cancer; 2013 Mar; 132(6):1429-38. PubMed ID: 22886725
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
27. Capecitabine for skin cancer prevention in solid organ transplant recipients.
Jirakulaporn T; Endrizzi B; Lindgren B; Mathew J; Lee PK; Dudek AZ
Clin Transplant; 2011; 25(4):541-8. PubMed ID: 21050273
[TBL] [Abstract][Full Text] [Related]
28. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
30. Increased Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Patients on Chronic Dialysis: A Cancer Registry-based Study in Taiwan.
Tang CH; Sue YM; Hsieh WT; Wang YH; Wang CC
Acta Derm Venereol; 2019 Dec; 99(13):1275-1281. PubMed ID: 31631228
[TBL] [Abstract][Full Text] [Related]
31. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
32. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
33. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
Liew YCC; De Souza NNA; Sultana RG; Oh CC
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
[TBL] [Abstract][Full Text] [Related]
35. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
Asgari MM; Ray GT; Geier JL; Quesenberry CP
J Am Acad Dermatol; 2017 Apr; 76(4):632-638. PubMed ID: 28162854
[TBL] [Abstract][Full Text] [Related]
36. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
Harwood CA; Leedham-Green M; Leigh IM; Proby CM
Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Solomon-Cohen E; Reiss-Huss S; Hodak E; Davidovici B
Dermatology; 2022; 238(1):161-166. PubMed ID: 33902035
[TBL] [Abstract][Full Text] [Related]
38. Skin Cancer in Non-White Solid Organ Transplant Recipients: Mayo Clinic Experience.
Zieman D; Heckman M; Brushaber D; Degesys C; Tolaymat L
South Med J; 2023 Oct; 116(10):839-844. PubMed ID: 37788820
[TBL] [Abstract][Full Text] [Related]
39. Periocular Skin Cancer in Solid Organ Transplant Recipients.
Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
[TBL] [Abstract][Full Text] [Related]
40. Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients.
Lanz J; Bouwes Bavinck JN; Westhuis M; Quint KD; Harwood CA; Nasir S; Van-de-Velde V; Proby CM; Ferrándiz C; Genders RE; Del Marmol V; Forchetti G; Hafner J; Vital DG; Hofbauer GFL
JAMA Dermatol; 2019 Jan; 155(1):66-71. PubMed ID: 30516812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]